Target Health
Aliath Bioventures aims to impact patients’ lives and healthcare systems working with entrepreneurs to create new healthcare solutions developed by sustainable companies.
Aliath is a life sciences venture capital investor and an investment advisor to AltamarCAM specialized in the life sciences and healthcare markets. Our team advises AltamarCAM on the life sciences investment strategy and its execution, by sourcing, structuring, and developing investments.
Inspired by our mission and driven by experience, talent, and alignment.
Our team is formed of industry veterans and investment experts with extensive knowledge of the healthcare ecosystem, complementary backgrounds, and proven professional track record. We invest alongside the funds´ investors and our carry is aligned with our impact goals.
Turn Healthcare challenges into business opportunities.
We seek companies built on disruptive trends that are providing an opportunity to address unmet medical needs and the sustainability of healthcare systems.
Innovation, Intention and Impact.
Aliath Bioventures aims to provide solutions to the most pressing healthcare challenges of our times by targeting therapeutics and health technology companies, from seed to late stage. We follow our 3-i framework (innovation, intention, impact) and apply impact principles and standards.
Build better companies.
We target sustainable and competitive companies. The primary goal of ACP Aliath Bioventures II is to achieve competitive financial returns developing sustainable companies. We design protocols to help portfolio companies be sustainable and work hand in hand with their management to improve their sustainability.
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced
Inbiomotion and SPA – Società Prodotti Antibiotici (SPA Farma) sign an exclusive agreement for MAF Test in Italy
SPA Farma, a leading pharmaceutical company of innovative healthcare products and diagnostic tools, and
Ultrathin Graphene Brain Implant Was Just Tested in a Person
A Spanish biotech company sees the carbon material as a way to power the
Peptomyc Expands its Patent Portfolio with a Patent Grant in Hong Kong for its Methods and Composition for the Treatment of Cancer
Peptomyc S.L., a company developing foundational mini-protein therapeutics for the treatment of cancer, announces
Todosalud Incorporates Mediktor’s AI into Its Services as Part of Its Commitment to Innovation
Synergia Inversiones and Negocios S.A.S. are adding Mediktor’s advanced AI virtual assistant, called Frank,
Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions
Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San
